Imperial College London

Dr Sofia Pappa MD, Ph.D

Faculty of MedicineDepartment of Brain Sciences

Honorary Senior Lecturer
 
 
 
//

Contact

 

s.pappa

 
 
//

Location

 

Charing Cross HospitalCharing Cross Campus

//

Summary

 

Summary

Dr Sofia Pappa is an Honorary Senior Lecturer at Imperial College London and NW London Specialty Lead in Mental Health for the National Institute for Health Research (NIHR). She also works as a Consultant Psychiatrist and Mood & Psychosis Research Lead at West London NHS Trust.

She has dual training in Neurology and Psychiatry and was awarded a European scholarship for the completion of her PhD. She subsequently obtained a fellowship for postdoctoral research at the Institute of Psychiatry, Kings College London, evaluating the neuromotor dysfunction in early psychosis.

Her research interests include psychopharmacology and the treatment of mood, psychotic and movement disorders. She has also a keen interest in the interface between physical and mental health as well as public & patient involvement (PPI) and co-production.

She has received a number of awards and grants and has acted as Principal Investigator for numerous clinical trials. She has published in high impact journals and regularly reviews manuscripts for top ranked journals and NIHR portfolio applications.

Furthermore, Dr Pappa has significant experience in teaching including in her roles as Imperial Medical School Tutor and Recovery College Tutor and in clinical management, having served as Clinical Lead for Adult Mental Health Services in the past.

Publications

Journals

O'Driscoll C, Shaikh M, Finamore C, et al., 2021, Profiles and trajectories of mental health service utilisation during early intervention in psychosis., Schizophr Res, Vol:237, Pages:47-53

Dewa L, Kalniunas A, Orleans-Foli S, et al., 2021, Detecting signs of deterioration in young patients with serious mental illness: a systematic review, Systematic Reviews, ISSN:2046-4053

Pappa S, Sakkas N, Sakka E, 2021, A year in review: sleep dysfunction and psychological distress in healthcare workers during the COVID-19 pandemic., Sleep Med

Mason K, Barnett J, Pappa S, 2021, Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate, Therapeutic Advances in Psychopharmacology, Vol:11, ISSN:2045-1253

Pungor K, Sanchez P, Pappa S, et al., 2021, The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia, Bmc Psychiatry, Vol:21

More Publications